Nagashree Seetharamu MD
Assistant Professor, Medicine, New York University School of Medicine
Join to View Full Profile
27005 76th AveNew Hyde Park, NY 11040
Phone+1 917-574-8494
Fax+1 516-734-8950
Dr. Seetharamu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2007
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2003 - 2006
Government Medical College VijayanagarClass of 1996
Certifications & Licensure
NY State Medical License 2006 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jul 19
- Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
Publications & Presentations
PubMed
- 50 years of Progress in Non-Small Cell Lung Cancer: A New Fellow's Guide in the Clinic.Jarushka Naidoo, Abesh Niroula, Dipesh Uprety, Matthew Smeltzer, Nicole Geissen
Journal of Thoracic Oncology. 2025-07-03 - Lymphovascular Invasion is a Predictor of Postoperative Recurrence or Death in Stage I Non-small-cell Lung Cancer (NSCLC).Margaret Locke, Wint Yan Aung, Michael Esposito, Nagashree Seetharamu
Clinical Lung Cancer. 2025-07-03 - 1 citationsRandomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity.Benedict J Panizza, Stephen John O'Leary, Christopher David Hart, Chandra Sai Diwakarla, Catherine Barnett
Journal of Clinical Oncology. 2025-07-01
Journal Articles
- Caring for Patients with Cancer in the Face of Self-Vulnerability During the COVID-19 Pandemic—ReplyNagashree Seetharamu, MD, JAMA Oncology
Authored Content
- Caring for Patients with Cancer in the Face of Self-Vulnerability During the COVID-19 Pandemic—ReplyAugust 2020
Press Mentions
Many with Advanced Lung Cancer Don't Get Treatments That Might HelpJanuary 21st, 2017
Lung Cancer Pill Halves Risk of Death in Some PeopleJune 9th, 2023- Lung Cancer Pill Halves Risk of Death in Some PeopleOctober 5th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
